Amir Faisal

2.2k total citations
68 papers, 1.4k citations indexed

About

Amir Faisal is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Amir Faisal has authored 68 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 27 papers in Cell Biology and 16 papers in Oncology. Recurrent topics in Amir Faisal's work include Microtubule and mitosis dynamics (24 papers), Cancer-related Molecular Pathways (10 papers) and Protein Degradation and Inhibitors (6 papers). Amir Faisal is often cited by papers focused on Microtubule and mitosis dynamics (24 papers), Cancer-related Molecular Pathways (10 papers) and Protein Degradation and Inhibitors (6 papers). Amir Faisal collaborates with scholars based in Pakistan, United Kingdom and Saudi Arabia. Amir Faisal's co-authors include Yoshikuni Nagamine, Sandra Kleiner, István Arany, Spiros Linardopoulos, Adrian T. Saurin, Peter J. Parker, Michiaki Nagasawa, Malgorzata Kisielow, Rahman Shah Zaib Saleem and Vassilios Bavetsias and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Amir Faisal

66 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Faisal Pakistan 23 880 294 212 210 109 68 1.4k
Carla Rozzo Italy 19 1.0k 1.1× 247 0.8× 246 1.2× 162 0.8× 85 0.8× 45 1.9k
Katarina Jovanović Serbia 22 1.0k 1.2× 105 0.4× 282 1.3× 169 0.8× 91 0.8× 47 1.6k
Masahiko Ikekita Japan 25 986 1.1× 169 0.6× 133 0.6× 263 1.3× 65 0.6× 96 1.7k
Claudia Götz Germany 25 1.2k 1.4× 284 1.0× 430 2.0× 130 0.6× 43 0.4× 89 1.7k
Zhongtao Zhang United States 26 1.4k 1.6× 209 0.7× 426 2.0× 119 0.6× 87 0.8× 36 2.1k
Julie A. Zorn United States 16 947 1.1× 90 0.3× 265 1.3× 226 1.1× 96 0.9× 21 1.5k
Euan Murray United States 22 1.0k 1.2× 297 1.0× 344 1.6× 230 1.1× 27 0.2× 44 1.9k
Asma M. Aman Canada 20 693 0.8× 96 0.3× 238 1.1× 196 0.9× 32 0.3× 45 1.5k
G. Prem Veer Reddy United States 22 1.3k 1.5× 124 0.4× 376 1.8× 114 0.5× 124 1.1× 33 1.8k
Tomohiro Kawamoto Japan 24 1.1k 1.3× 232 0.8× 301 1.4× 473 2.3× 33 0.3× 61 1.9k

Countries citing papers authored by Amir Faisal

Since Specialization
Citations

This map shows the geographic impact of Amir Faisal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Faisal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Faisal more than expected).

Fields of papers citing papers by Amir Faisal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Faisal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Faisal. The network helps show where Amir Faisal may publish in the future.

Co-authorship network of co-authors of Amir Faisal

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Faisal. A scholar is included among the top collaborators of Amir Faisal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Faisal. Amir Faisal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Paul N., Habib Nasir, Shazia Nisar, et al.. (2025). Biosynthesis and characterization of silver nanoparticles from Asplenium dalhousiae and their potential biological properties. PLoS ONE. 20(6). e0325533–e0325533. 1 indexed citations
2.
Bibi, Amina, et al.. (2025). CanSeer: a translational methodology for developing personalized cancer models and therapeutics. Scientific Reports. 15(1). 15080–15080. 1 indexed citations
3.
Shaheen, Samir I., Iftikhar Ali, Amir Faisal, et al.. (2025). Bicyclic 2-aminopyrimidine derivatives as potent VEGFR-2 inhibitors and apoptosis Inducers: Structure-Guided design, synthesis, anticancer assessment, and in-silico exploration. European Journal of Medicinal Chemistry. 293. 117726–117726.
4.
Arif, Muhammad, Sadia Sarwar, Rahman Shah Zaib Saleem, et al.. (2024). Discovery and prospects of new heterocyclic Isatin-hydrazide derivative with a novel role as estrogen receptor α degrader in breast cancer cells. Frontiers in Chemistry. 12. 1424637–1424637. 2 indexed citations
5.
Faisal, Amir, et al.. (2023). Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B/NS3 protease inhibitors. Archiv der Pharmazie. 356(11). e2300292–e2300292. 7 indexed citations
6.
Faisal, Amir, et al.. (2023). Spontaneous NETosis in diabetes: A role of hyperglycemia mediated ROS and autophagy. Frontiers in Medicine. 10. 1076690–1076690. 17 indexed citations
7.
Furqan, Muhammad, Rahim Ullah, Muhammad Muddassar, et al.. (2021). CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells. British Journal of Cancer. 125(7). 966–974. 12 indexed citations
8.
9.
Moore, Andrew S., Amir Faisal, Grace Wing-Yan Mak, et al.. (2020). Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736. Blood Advances. 4(7). 1478–1491. 20 indexed citations
10.
Faisal, Amir, et al.. (2020). Colon specific enzyme responsive oligoester crosslinked dextran nanoparticles for controlled release of 5-fluorouracil. International Journal of Pharmaceutics. 586. 119605–119605. 44 indexed citations
11.
Furqan, Muhammad, et al.. (2020). A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance. PLoS ONE. 15(6). e0233993–e0233993. 17 indexed citations
12.
Hayes, Angela, Manjuan Liu, Butrus Atrash, et al.. (2019). Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species. European Journal of Pharmaceutical Sciences. 139. 104899–104899. 4 indexed citations
13.
Ullah, Rahim, Christelle de Renty, Melvin Depamphilis, et al.. (2018). CDK1 inhibition facilitates formation of syncytiotrophoblasts and expression of human Chorionic Gonadotropin. Placenta. 66. 57–64. 6 indexed citations
14.
Khan, Sardaraz, Rahim Ullah, Abdul‐Hamid Emwas, et al.. (2018). Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance. Scientific Reports. 8(1). 3305–3305. 26 indexed citations
15.
Gurden, Mark D., Isaac M. Westwood, Amir Faisal, et al.. (2015). Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance. Cancer Research. 75(16). 3340–3354. 24 indexed citations
16.
Faisal, Amir, Vassilios Bavetsias, Chongbo Sun, et al.. (2011). The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN -Amplified Neuroblastoma In Vivo. Molecular Cancer Therapeutics. 10(11). 2115–2123. 67 indexed citations
17.
Bouloc, Nathalie, Jonathan M. Large, Magda Kosmopoulou, et al.. (2010). Structure-based design of imidazo[1,2-a]pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells. Bioorganic & Medicinal Chemistry Letters. 20(20). 5988–5993. 27 indexed citations
18.
Faisal, Amir, Adrian T. Saurin, Bernard Gregory, Brian M. J. Foxwell, & Peter J. Parker. (2008). The Scaffold MyD88 Acts to Couple Protein Kinase Cϵ to Toll-like Receptors. Journal of Biological Chemistry. 283(27). 18591–18600. 46 indexed citations
19.
Tiberi, Luca, et al.. (2006). p66Shc gene has a pro-apoptotic role in human cell lines and it is activated by a p53-independent pathway. Biochemical and Biophysical Research Communications. 342(2). 503–508. 13 indexed citations
20.
Kisielow, Malgorzata, Sandra Kleiner, Michiaki Nagasawa, Amir Faisal, & Yoshikuni Nagamine. (2002). Isoform-specific knockdown and expression of adaptor protein ShcA using small interfering RNA. Biochemical Journal. 363(1). 1–1. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Rozzo Breakdown of academic impact, for papers by Katarina Jovanović Breakdown of academic impact, for papers by Masahiko Ikekita Breakdown of academic impact, for papers by Claudia Götz Breakdown of academic impact, for papers by Zhongtao Zhang Breakdown of academic impact, for papers by Julie A. Zorn Breakdown of academic impact, for papers by Euan Murray Breakdown of academic impact, for papers by Asma M. Aman Breakdown of academic impact, for papers by G. Prem Veer Reddy Breakdown of academic impact, for papers by Tomohiro Kawamoto
Rankless by CCL
2026